652 related articles for article (PubMed ID: 25812086)
1. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
2. Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
[TBL] [Abstract][Full Text] [Related]
3. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
4. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
[TBL] [Abstract][Full Text] [Related]
5. In Southern Nigeria
Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
[TBL] [Abstract][Full Text] [Related]
6. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
7. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
8. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
Esum M; Wanji S; Tendongfor N; Enyong P
Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
[TBL] [Abstract][Full Text] [Related]
9. Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).
Adeoye GO; Akinsanya B; Otubanjo AO; Ibidapo CA; Atalabi T; Okwuzu J; Adejai EO; Braide EI
Ann Trop Med Parasitol; 2008 Apr; 102(3):215-27. PubMed ID: 18348776
[TBL] [Abstract][Full Text] [Related]
10. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
[TBL] [Abstract][Full Text] [Related]
11. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
[TBL] [Abstract][Full Text] [Related]
12. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
[TBL] [Abstract][Full Text] [Related]
13. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
[TBL] [Abstract][Full Text] [Related]
14. Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.
Hassan AA; Akinsanya B; Iyase N; Owagboriaye FO
Korean J Parasitol; 2011 Jun; 49(2):153-9. PubMed ID: 21738271
[TBL] [Abstract][Full Text] [Related]
15. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
16. Validation of the rapid assessment procedure for loiasis (RAPLOA) in the Democratic Republic of Congo.
Wanji S; Akotshi DO; Mutro MN; Tepage F; Ukety TO; Diggle PJ; Remme JH
Parasit Vectors; 2012 Feb; 5():25. PubMed ID: 22300872
[TBL] [Abstract][Full Text] [Related]
17. Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.
Ibidapo CA; Akinsanya B; Adeoye GO; Otubanjo AO; Okeke P; Okwuzu J; Adejai EO; Braide E
West Indian Med J; 2008 Mar; 57(2):152-6. PubMed ID: 19565959
[TBL] [Abstract][Full Text] [Related]
18. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
Wanji S; Tendongfor N; Esum M; Ndindeng S; Enyong P
Med Microbiol Immunol; 2003 Feb; 192(1):15-21. PubMed ID: 12592559
[TBL] [Abstract][Full Text] [Related]
20. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
